Phathom Pharmaceuticals, Inc. — Director's Dealing 2024

Jan 26, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2024-01-24

Reporting Person: Medicxi Ventures Management (Jersey) Ltd (N/A)
Reporting Person: Medicxi Growth I GP Ltd (N/A)
Reporting Person: Medicxi Growth I LP (N/A)
Reporting Person: Medicxi Growth Co-Invest I LP (N/A)
Reporting Person: Medicxi IV GP Ltd (N/A)
Reporting Person: Medicxi IV LP (N/A)
Reporting Person: Medicxi Co-Invest IV LP (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3673602	Indirect
Common Stock	87267	Indirect
Common Stock	3641728	Indirect
Common Stock	61975	Indirect

Footnotes

F1: Shares held by Medicxi Growth I LP ("Growth I"). Medicxi Growth I GP Limited ("Growth I GP") is the sole general partner of Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the sole manager of Growth I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Growth I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.

F2: Shares held by Medicxi Growth Co-Invest I LP ("Growth Co-Invest I"). Growth I GP is the sole general partner of Growth Co-Invest I, and Medicxi Manager is the sole manager of Growth Co-Invest I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Growth Co-Invest I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.

F3: Shares held Medicxi IV LP ("Medicxi IV"). Medicxi IV GP Limited ("Medicxi IV GP") is the sole general partner of Medicxi IV, and Medicxi Manager is the sole manager of Medicxi IV. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi IV, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.

F4: Shares held by Medicxi Co-Invest IV LP ("Co-Invest IV"). Medicxi IV GP is the sole general partner of Co-Invest IV, and Medicxi Manager is the sole manager of Co-Invest IV. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Co-Invest IV, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.